The Use of MiniMed780G System Is Associated With Stable Glycemic Control in People With Type 1 Diabetes Before, During, and After Ramadan: An Observational Study
Conclusion: The use of the MiniMed780G system is safe with favorable glycemic outcomes across nonfasting and fasting months.
Saved in:
| Main Authors: | Abdullah M. Alguwaihes, Najla Alotaibi, Metib Alotaibi, Naglaa Masry, Saher Safarini |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Journal of Diabetes Research |
| Online Access: | http://dx.doi.org/10.1155/jdr/4144787 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Altered Ramadan fasting glycemic profiles of adults with type 1 diabetes reveal strong evidence of underestimated insulin adjustments: a 3-year observational study in Arab settings
by: Abdullah M. Alguwaihes, et al.
Published: (2025-05-01) -
Time in Tight Range in AHCL Systems: Propensity-Score-Matched Analysis of MiniMed 780G and Control-IQ
by: María Sara Tapia Sanchiz, et al.
Published: (2025-07-01) -
Real world efficacy and safety of the advanced hybrid closed-loop system MiniMed 780G (SmartGuard) in children under 7 years of age
by: Sara López-López, et al.
Published: (2025-01-01) -
Diabetes management during and after Ramadan among pregnant women in Saudi Arabia: exploring self-efficacy, self-care, and glycemic control
by: Omar Mohammed Alamri, et al.
Published: (2025-08-01) -
The effect of self glucose monitoring on glycemic control of patients with diabetes mellitus fasting during Ramadan
by: Seydahmet Akın, et al.
Published: (2022-03-01)